Loading...
Header Logo
Keywords
Last Name
Institution

NEEMA NAVAI

TitleAssistant Professor
InstitutionMD Anderson
DepartmentUrology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lim AH, Narayan VM, Navai N. The Role of Surgery in Initially Metastatic Urothelial Carcinoma: Informing a Definitive Trial. Eur Urol Oncol. 2019 Sep 06. PMID: 31501083.
      View in: PubMed
    2. Li R, Kukreja JEB, Seif MA, Petros FG, Campbell MT, Nguyen JV, González GMN, Kamat AM, Pisters LL, Dinney CP, Navai N. The role of metastatic burden in cytoreductive/consolidative radical cystectomy. World J Urol. 2019 Mar 12. PMID: 30864005.
      View in: PubMed
    3. Marcus RK, Lillemoe HA, Rice DC, Mena G, Bednarski BK, Speer BB, Ramirez PT, Lasala JD, Navai N, Williams WH, Kim BJ, Voss RK, Gottumukkala VN, Aloia TA. Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis. Ann Surg Oncol. 2019 Mar; 26(3):782-790. PMID: 30627879.
      View in: PubMed
    4. Li R, Tabayoyong WB, Guo CC, González GMN, Navai N, Grossman HB, Dinney CP, Kamat AM. Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease. Eur Urol. 2019 01; 75(1):8-10. PMID: 30301695.
      View in: PubMed
    5. Li R, Metcalfe MJ, Tabayoyong WB, Guo CC, Nogueras González GM, Navai N, Grossman HB, Dinney CP, Kamat AM. Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign. Eur Urol Oncol. 2019 May; 2(3):286-293. PMID: 31200843.
      View in: PubMed
    6. Kukreja JB, Metcalfe MJ, Qiao W, Kamat AM, Dinney CPN, Navai N. Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort. Eur Urol Focus. 2018 Jul 19. PMID: 30033071.
      View in: PubMed
    7. Balasubramanian A, Metcalfe MJ, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF. Salvage topical therapy for upper tract urothelial carcinoma. World J Urol. 2018 Dec; 36(12):2027-2034. PMID: 29804202.
      View in: PubMed
    8. Mmeje CO, Benson CR, Nogueras-González GM, Jayaratna IS, Gao J, Siefker-Radtke AO, Kamat AM, Dinney CP, Navai N, Shah JB. Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy. BJU Int. 2018 07; 122(1):89-98. PMID: 29569824.
      View in: PubMed
    9. Kukreja JB, Shi Q, Chang CM, Seif MA, Sterling BM, Chen TY, Creel KM, Kamat AM, Dinney CP, Navai N, Shah JB, Wang XS. Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy. Surg Innov. 2018 Jun; 25(3):242-250. PMID: 29557251.
      View in: PubMed
    10. Li R, Metcalfe M, Kukreja J, Navai N. Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review. Bladder Cancer. 2018 Jan 20; 4(1):31-40. PMID: 29430505.
      View in: PubMed
    11. Chapin BF, Nguyen JN, Achim MF, Navai N, Williams SB, Prokhorova IN, Wang X, Tapia EMLN, Davis JW, Troncoso P. Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer. Prostate Cancer Prostatic Dis. 2018 06; 21(2):221-227. PMID: 29230008.
      View in: PubMed
    12. Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int. 2018 04; 121(4):540-548. PMID: 28941030.
      View in: PubMed
    13. Li R, Metcalfe MJ, Ferguson JE, Mokkapati S, Nogueras González GM, Dinney CP, Navai N, McConkey DJ, Sahai SK, Kamat AM. Effects of thiazolidinedione in patients with active bladder cancer. BJU Int. 2018 02; 121(2):244-251. PMID: 28872778.
      View in: PubMed
    14. Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Navai N, Achim MF, Wang X, Chen HC, Choi S, Kuban D, Troncoso P, Hanash S, Thompson TC, Kim J. Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer. BJU Int. 2018 01; 121(1):69-76. PMID: 28710901.
      View in: PubMed
    15. Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes. J Endourol. 2017 09; 31(9):946-953. PMID: 28731777.
      View in: PubMed
    16. Metcalfe MJ, Ferguson JE, Li R, Xiao L, Guo CC, Czerniak BA, Siefker-Radtke A, Pretzsch SM, Navai N, McConkey DJ, Kamat AM, Campbell M, Dinney C. Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion. Eur Urol Focus. 2017 12; 3(6):577-583. PMID: 28753816.
      View in: PubMed
    17. Roth B, Jayaratna I, Sundi D, Cheng T, Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M, Guo C, Czerniak B, McConkey D, Dinney C. Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. Oncotarget. 2017 May 23; 8(21):34205-34222. PMID: 27494900.
      View in: PubMed
    18. Kukreja JB, Porten S, Golla V, Ho PL, Noguera-Gonzalez G, Navai N, Kamat AM, Dinney CPN, Shah JB. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. Eur Urol Focus. 2018 09; 4(5):720-724. PMID: 28753837.
      View in: PubMed
    19. Biebighauser KC, Gao J, Rao P, Landon G, Pagliaro L, Dinney CPN, Karam J, Navai N. Non-seminomatous germ cell tumor with bone metastasis only at diagnosis: A rare clinical presentation. Asian J Urol. 2017 Apr; 4(2):124-127. PMID: 29264217.
      View in: PubMed
    20. Navai N, Benedict WF, Zhang G, Abraham A, Ainslie N, Shah JB, Grossman HB, Kamat AM, Dinney CP. Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon a2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer. Ann Surg Oncol. 2016 11; 23(12):4110-4114. PMID: 27387678.
      View in: PubMed
    21. Navai N, Dinney CP. Oncologic Equivalence between Laparoscopic/Robotic and Open Radical Cystectomy. J Urol. 2016 06; 195(6):1646-7. PMID: 26994308.
      View in: PubMed
    22. Mmeje CO, Guo CC, Shah JB, Navai N, Grossman HB, Dinney CP, Kamat AM. Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design. Eur Urol. 2016 11; 70(5):778-785. PMID: 26922408.
      View in: PubMed
    23. Ho PL, Willis DL, Patil J, Xiao L, Williams SB, Melquist JJ, Tart K, Parikh S, Shah JB, Delacroix SE, Navai N, Siefker-Radtke A, Dinney CP, Pisters LL, Kamat AM. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. Urol Oncol. 2016 Feb; 34(2):59.e1-8. PMID: 26421586.
      View in: PubMed
    24. Jayaratna IS, Navai N, Dinney CP. Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer. Transl Androl Urol. 2015 Jun; 4(3):273-82. PMID: 26816830.
      View in: PubMed
    25. Navai N, Matin SF. Words of wisdom. Re: A randomized trial of robot-assisted laparoscopic radical cystectomy. Eur Urol. 2015 Jan; 67(1):173-174. PMID: 25528394.
      View in: PubMed
    26. Solomon DA, Kim JS, Bondaruk J, Shariat SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, Navai N, Siefker-Radtke A, Phillips JJ, Robinson BD, Rubin MA, Volkmer B, Hautmann R, Küfer R, Hogendoorn PC, Netto G, Theodorescu D, James CD, Czerniak B, Miettinen M, Waldman T. Frequent truncating mutations of STAG2 in bladder cancer. Nat Genet. 2013 Dec; 45(12):1428-30. PMID: 24121789.
      View in: PubMed
    27. Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CP. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol. 2014 Jan; 191(1):40-7. PMID: 23911605.
      View in: PubMed
    28. Dinney CP, Fisher MB, Navai N, O'Donnell MA, Cutler D, Abraham A, Young S, Hutchins B, Caceres M, Kishnani N, Sode G, Cullen C, Zhang G, Grossman HB, Kamat AM, Gonzales M, Kincaid M, Ainslie N, Maneval DC, Wszolek MF, Benedict WF. Phase I trial of intravesical recombinant adenovirus mediated interferon-a2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer. J Urol. 2013 Sep; 190(3):850-6. PMID: 23507396.
      View in: PubMed
    29. Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B, Dinney C, Barton M, McConkey DJ. The p63 protein isoform ?Np63a inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J Biol Chem. 2013 Feb 01; 288(5):3275-88. PMID: 23239884.
      View in: PubMed
    30. Navai N, Wood CG. Environmental and modifiable risk factors in renal cell carcinoma. Urol Oncol. 2012 Mar-Apr; 30(2):220-4. PMID: 22385993.
      View in: PubMed
    31. Rebuck DA, Zhao LC, Helfand BT, Casey JT, Navai N, Perry KT, Nadler RB. Simple modifications in operating room processes to reduce the times and costs associated with robot-assisted laparoscopic radical prostatectomy. J Endourol. 2011 Jun; 25(6):955-60. PMID: 21457071.
      View in: PubMed
    32. Alphs HH, Navai N, Köhler TS, McVary KT. Preoperative clinical and diagnostic characteristics of patients who require delayed IPP after primary Peyronies repair. J Sex Med. 2010 Mar; 7(3):1262-8. PMID: 20059657.
      View in: PubMed
    33. Nadler RB, Casey JT, Zhao LC, Navai N, Smith ZL, Zhumkhawala A, Macejko AM. Is the transition from open to robotic prostatectomy fair to your patients? A single-surgeon comparison with 2-year follow-up. J Robot Surg. 2010 Jan; 3(4):201-7. PMID: 27628630.
      View in: PubMed
    34. Meeks JJ, Zhao LC, Navai N, Perry KT, Nadler RB, Smith ND. Risk factors and management of urine leaks after partial nephrectomy. J Urol. 2008 Dec; 180(6):2375-8. PMID: 18930268.
      View in: PubMed
    35. Navai N, Erickson BA, Zhao LC, Okotie OT, Gonzalez CM. Complications following urethral reconstructive surgery: a six year experience. Int Braz J Urol. 2008 Sep-Oct; 34(5):594-600; discussion 601. PMID: 18986563.
      View in: PubMed
    36. Navai N, Ramos P, Zhao LC, Meeks JJ, Nadler RB, Smith ND. Why not partial nephrectomy? Urology. 2008 Aug; 72(2):243-6. PMID: 18584853.
      View in: PubMed
    37. Casey JT, Erickson BA, Navai N, Zhao LC, Meeks JJ, Gonzalez CM. Urethral reconstruction in patients with neurogenic bladder dysfunction. J Urol. 2008 Jul; 180(1):197-200. PMID: 18499188.
      View in: PubMed
    38. Erickson BA, Navai N, Patil M, Chang A, Gonzalez CM. A prospective, randomized trial evaluating the use of hydrogel coated latex versus all silicone urethral catheters after urethral reconstructive surgery. J Urol. 2008 Jan; 179(1):203-6. PMID: 18001794.
      View in: PubMed
    39. Navai N, Yap RL, Gupta R, Fraser TG, Gonzalez CM. Inflammatory pseudotumor of the testis: a novel presentation of acute retroviral syndrome. Int J Urol. 2005 Apr; 12(4):424-6. PMID: 15948738.
      View in: PubMed
    40. Saporita AJ, Zhang Q, Navai N, Dincer Z, Hahn J, Cai X, Wang Z. Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor. J Biol Chem. 2003 Oct 24; 278(43):41998-2005. PMID: 12923188.
      View in: PubMed
    41. Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy. European Urology.
    42. Is the transition from open to robotic prostatectomy fair to your patients? A single-surgeon comparison with 2-year follow-up. Journal of Robotic Surgery. 3:201-207.
    43. Preoperative clinical and diagnostic characteristics of patients who require delayed ipp after primary Peyronie's repair. Journal of Urology. 184:1392-1393.
    44. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy. Urologic Oncology: Seminars and Original Investigations. 34:59.e1-59.e8.
    45. Annals of Surgical Oncology. 1-5.
    46. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. European Urology Focus.
    47. In vivo microwave-induced porcine kidney thermoablation. Journal of Endourology. 25:908-909.
    48. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles - Commentary. Journal of Endourology. 25:909-910.
    49. Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer. Translational Andrology and Urology. 4:273-282.
    50. Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor. European Urology, Supplements. 2.
    51. Oncologic Equivalence between Laparoscopic/Robotic and Open Radical Cystectomy. Journal of Urology. 195:1646-1647.
    NAVAI's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description